BiotechTube
Home/AnaptysBio/Dennis Fenton
DF

Dennis Fenton

Board Member

AnaptysBio

Therapeutic Areas

Autoimmune DiseasesInflammatory Diseases

AnaptysBio Pipeline

DrugIndicationPhase
ANB033Celiac Disease, Eosinophilic EsophagitisPhase 1
Rosnilimab (ANB030)Rheumatoid ArthritisPhase 2b
ANB101Undisclosed Inflammatory IndicationsPhase 1

Leadership Team at AnaptysBio

DF
Daniel Faga
President & CEO
DM
Dennis Mulroy
Chief Financial Officer
PF
Paul F. Lizzul
Chief Medical Officer
EL
Eric Loumeau
Chief Legal Officer
MD
Martin Dahl
SVP, Research
CS
Cailin Sibley
SVP, Translational Medicine
MD
Monique da Silva
SVP, Corporate Affairs
BS
Ben Stone
Chief Business Officer
PR
Priya Raina
SVP, Clinical Operations
BM
Beth Mueller
SVP, Human Resources
View full AnaptysBio profile